DR. JOHN CARTEN MCLAUGHLIN, PSYD.
Psychologist at Fell St, San Francisco, CA
License number
California PSY20559
Category
Psychologist
Type
Psychologist
Address
Address
295 Fell St SUITE A, San Francisco, CA 94102
Phone
(415) 861-7690
Personal information
See more information about JOHN CARTEN MCLAUGHLIN at radaris.comName
Address
Phone
4919 Cronin Ct, Fair Oaks, CA 95628
500 Ramona Ave, Monterey, CA 93940
44405 Willow Cir, La Quinta, CA 92253
4424 Algeciras St, San Diego, CA 92107
4757 Hillsboro Cir, Santa Rosa, CA 95405
Professional information
See more information about JOHN CARTEN MCLAUGHLIN at trustoria.com
Cfo At Safetychain Software, Inc.
Cfo At Safetychain Software, Inc.
Position:
CFO at SafetyChain Software
Location:
San Francisco Bay Area
Industry:
Computer Software
Work:
SafetyChain Software
- San Rafael, CA since Nov 2011
-
CFO
Enwisen
- Novato, CA Aug 2007 - Jul 2011
-
CFO
Education:
Thunderbird School of Global Management
MBA, International Management
MBA, International Management
Languages:
English, Spanish
President At Silicon Valley Historical Association
President At Silicon Valley Historical Association
Position:
President at Silicon Valley Historical Association
Location:
San Francisco Bay Area
Industry:
Media Production
Work:
Silicon Valley Historical Association
since 1992
-
President
Education:
United States International University 1972 - 1974
Masters of International Business Administration, International Marketing & Finance University of Oregon 1967 - 1971
Bachelor of Science, Political Science
Masters of International Business Administration, International Marketing & Finance University of Oregon 1967 - 1971
Bachelor of Science, Political Science
John Carten McLaughlin, San Francisco CA
John Carten McLaughlin, San Francisco CA
Specialties:
Psychologist
Address:
295 Fell St, San Francisco, CA 94102
Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
US Patent:
2013021, Aug 15, 2013
Filed:
Feb 1, 2013
Appl. No.:
13/757262
Inventors:
Rigel Pharmaceuticals, Inc. - , US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Vadim Markovtsov - San Mateo CA, US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Vadim Markovtsov - San Mateo CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 239/48, C07D 401/12, C07D 471/08, C07D 295/155, C07D 403/12, C07D 417/12, C07D 413/12
US Classification:
5142278, 435375, 5142305, 5142358, 51425214, 514275
Abstract:
The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.
Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
US Patent:
7858633, Dec 28, 2010
Filed:
Dec 6, 2006
Appl. No.:
11/567276
Inventors:
Hui Li - Millbrae CA, US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Mark Markovtsov - Foster City CA, US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Mark Markovtsov - Foster City CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 239/48, A61K 31/506
US Classification:
514275, 544323
Abstract:
The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.